Press release
Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Intelligence Revolutionizes Neuropathic Pain Treatment Industry Transformation
Neuropathic Pain
Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025?
The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%; this upward trend observed during the past timeframe stems from several contributing factors, including the escalating need for pharmacological interventions for neuropathic pain, the widespread prevalence of chronic pain conditions, rising consumer appetite for prescribed therapies, and supportive governmental actions.
How Will the Neuropathic Pain Market Size Evolve and Grow by 2029?
Anticipating robust expansion, the market dedicated to neuropathic pain is projected to reach a valuation of $7.78 billion by the year 2029, achieving a compound annual growth rate (CAGR) of 7.7% over the coming period; this upward trajectory is underpinned by several factors, including heightened recognition of neuropathic pain conditions, the increasing global aging demographic, expanding reach of healthcare infrastructure, and better availability of therapeutic options for managing this type of pain, while key developments shaping this market landscape involve sophisticated diagnostic methods, progress in pain control techniques, strides in pertinent medical investigation, the introduction of novel pharmaceutical agents, and proactive strategic undertakings.
View the full report here:
https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report
What Drivers Are Propelling the Growth of Neuropathic Pain Market Forward?
The increasing incidence of long-term pain conditions is anticipated to fuel the expansion of the neuropathic pain market in the near future. Persistent pain, defined as discomfort that continues past the expected recovery period from an ailment or injury, is a defining feature of chronic pain, usually persisting for a minimum of three to six months or longer. As chronic pain, which encompasses neuropathic disorders, becomes more widespread, there is a greater demand for efficacious therapeutic approaches, thereby stimulating advancements, novel solutions, and financial commitment toward better treatments aimed at improving symptom management and overall well-being. To illustrate this trend, data released in December 2023 by the Scottish Government through the Scottish Health Survey 2022 indicated that in 2022, over a third (38%) of adults residing in Scotland experienced pain or unease persisting for three months or longer, with this issue being more common among females (43%) than males (33%). Consequently, the increasing rate of chronic pain is serving as a main catalyst for the expansion of the neuropathic pain sector.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12922&type=smp
Which Emerging Trends Are Transforming the Neuropathic Pain Market in 2025?
Leading firms within the neuropathic pain sector are integrating artificial intelligence capabilities across various facets, including sophisticated diagnostic processes, personalized therapeutic regimens, continuous progress surveillance, pharmaceutical research, and leveraging data analytics to elevate patient results and sharpen pain management approaches. Specifically, in March of 2023, the American medical device corporation Nevro Corp. introduced its Senza HFX iQ spinal cord stimulation (SCS) platform. This cutting-edge solution utilizes AI to tailor pain relief specifically to each individual patient. Comprised of the HFX iQ Implantable Pulse Generator (IPG), the HFX Trial Stimulator, a Charger, and the accompanying HFX Application, the design targets intractable non-surgical back pain and debilitating diabetic neuropathy through dynamic adjustments based on patient reactions and input. Furthermore, it leverages a proprietary algorithm informed by substantial patient datasets and grants users the ability to modify their pain management schedule through a mobile phone application. This digital ecosystem facilitates comprehensive data gathering and opens possibilities for future enhancements, ultimately striving to boost the efficacy of pain relief by ensuring both reliability and customization, representing a noteworthy progression in the field of SCS treatment.
What Are the Key Segments in the Neuropathic Pain Market?
The neuropathic painmarket covered in this report is segmented -
1) By Treatment: Medications; Multimodal Therapy
2) By Diagnosis: Imaging; Blood Tests And Physical Examination
3) By Indication: Diabetic Neuropathy; Spinal Stenosis; Chemotherapy-Induced Peripheral Neuropathy; Other Indications
4) By End User: Hospitals; Clinics; Home Healthcare; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Medications: Anticonvulsants; Antidepressants; Opioids; Topical Treatments; Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2) By Multimodal Therapy: Combination Of Medications; Physical Therapy; Psychological Therapy; Lifestyle Modifications; Complementary Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12922&type=smp
Who Are the Key Players Shaping the Neuropathic Pain Market's Competitive Landscape?
Major companies operating in the neuropathic pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Medtronic Inc., Eli Lilly and Company, Stryker Corporation, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific Corporation, Biogen Inc., Zimmer Biomet Holdings Inc., Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Grünenthal GmbH, Lupin Ltd., NuVasive Inc., Integer Holdings Corporation, Avanos Medical Inc., Orthofix Medical Inc., Nevro Corp., InvaGen Pharmaceuticals Inc., B. Braun Melsungen AG, Cirtec Medical Corp., Centaur Pharmaceuticals Pvt Ltd., Stimwave LLC, DePuy Synthes.
What Geographic Markets Are Powering Growth in the Neuropathic Pain Market?
North America was the largest region in the neuropathic pain market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in neuropathic pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12922
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Intelligence Revolutionizes Neuropathic Pain Treatment Industry Transformation here
News-ID: 4274965 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Neuropathic
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also…
